Lab Notes: Adaptimmune to expand manufacturing at Navy Yard; Helius raises $18M with stock sale
August 12, 2022 at 11:42 AM EDT
A Philadelphia biotechnology company gets orphan drug status for its new drug candidate.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following